August 2026
The stem cell umbilical cord blood market size totalled USD 18.57 billion in 2025, with major stem cell umbilical cord blood market players including Cord Blood Registry (CBR), Cryo-Cell International, Inc., ViaCord (PerkinElmer), Global Cord Blood Corporation.
September 2026
The global peripheral blood mononuclear cells market size was evaluated at USD 350.42 billion in 2026 and is predicted to hit around USD 842.89 billion by 2035, growing at a CAGR of 10.26%.
September 2026
The global stem cell banking market size was valued at USD 8.93 billion in 2026 and is expected to surpass around USD 27.71 billion by 2034 with a CAGR of 15.29%.
September 2026
The global stem cell manufacturing market size reached USD 17.57 billion in 2026 and is projected to surpass around USD 45.38 billion by 2035, with a solid CAGR of 11.13%.
September 2026
The global stem cells market surpassed USD 20.79 Bn in 2026 and is projected to cross USD 53.32 Bn by 2035, growing at a CAGR of 11.08% from 2026 to 2035.
September 2026
The synthetic stem cells market size stood at USD 11.25 billion in 2026, with major synthetic stem cells market companies including Brainstorm Cell Therapeutics, Fate Therapeutics, Evotec, Cesca Therapeutics, VistaGen Therapeutics.
September 2026
The global large-scale active stem cell clinical trials market size was evaluated at USD 8.27 billion in 2026 and is predicted to hit around USD 28.88 billion by 2035, growing at a CAGR of 14.90%.
September 2026
The hematopoietic stem cell transplantation market size reached USD 12.69 billion in 2026, with leading hematopoietic stem cell transplantation market companies including Novartis, Gilead Sciences, Baxter International, Fresenius Kabi.
September 2026
The stem cell therapy for neurological disorders market generated USD 17.90 billion in 2026, with prominent stem cell therapy for neurological disorders market companies including BrainStorm Cell Therapeutics, Mesoblast, ReNeuron Group.
September 2026
The global cancer stem cells market size is anticipated to worth around USD 6.60 billion by 2034 from USD 2.69 billion in 2026 with a CAGR of 11.92%.
September 2026
The global induced pluripotent stem cells market size is estimated to hit around USD 5.57 billion by 2035, increasing from USD 2.13 billion in 2025, with a CAGR of 10.09%.
September 2026
The global stem cell transplantation market growth is driven by rising cancer cases, advances in regenerative medicine, and increasing stem cell research.
August 2026
The autologous stem cell and non-stem cell based therapies market size stood at USD 10.75 billion in 2026, with major autologous stem cell and non-stem cell based therapies market companies including Vericel Corporation, Holostem Terapie Avanzate, Anterogen Co. Ltd., BrainStorm Cell Therapeutics.
July 2026
The stem cell therapy market size is expected to increase from USD 18.13 billion in 2025 and it is predicted to hit USD 59.70 billion by 2035 at a CAGR of 12.66%.
June 2026
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
June 2026
The U.S. stem cell therapy market size reached USD 6.75 billion in 2025 and is projected to hit around USD 21.31 billion by 2035 with a remarkeble CAGR of 12.18%.
February 2026
The global cord blood banking services market size is estimated to hit around USD 6.17 billion by 2035 from USD 3.27 billion in 2025, with a notable CAGR of 6.55%.
January 2026
The global cord blood banking market size is valued at USD 18.56 billion in 2025 and is projected to surge around USD 30.14 billion by 2035 with a CAGR of 4.97%.
December 2025
The global automated and closed cell therapy processing system market size is expected to hit around USD 14.46 billion by 2035 with a CAGR of 22.76%.
December 2025
The global non-invasive blood glucose monitoring system market size is projected to hit around USD 300.45 billion by 2035 with a CAGR of 22.18% from 2026 to 2035.
August 2025
The global laser-based 3D bioprinting market size was evaluated at USD 1.54 billion in 2024 and is predicted to hit around USD 7.11 billion by 2034, growing at a CAGR of 16.53%.
September 2026
The pulmonary drug delivery systems market size reached USD 61.03 billion in 2026, with leading pulmonary drug delivery systems market companies including Philips Respironics, GlaxoSmithKline PLC, BoehringerIngelheim GmbH.
September 2026
The global energy retrofit systems market size was valued at USD 181.34 billion in 2026 and is projected to hit around USD 291.66 billion by 2034 with a CAGR of 6.12%.
September 2026
The cell and tissue preservation market reached USD 5.77 billion in 2026, featuring leading cell and tissue preservation companies such as lonza, chart industries, biolife solutions, thermos fisher scientific.
September 2026
The global mammalian cell fermentation technology market size is projected to hit around USD 128.16 billion by 2035 from USD 60.05 billion in 2026 with a CAGR of 8.80%.
September 2026
The global zero liquid discharge systems market size is projected to hit around USD 11.46 billion by 2034 from USD 7.45 billion in 2026, with a CAGR of 5.53%.
September 2026
The solar energy systems market size was evaluated at USD 344.85 billion in 2026 and is expected to cross around USD 1192.55 billion by 2035 with a CAGR of 14.92%
September 2026
The global clinical trial management system market size is expected to surge to around USD 7.28 billion by 2035 from USD 2.56 billion in 2026, with a CAGR of 12.36%.
September 2026
The global power grid system market size is calculated at USD 12.20 billion by 2026 and it is expected to hit around USD 21.26 billion by 2034 with a CAGR of 7.22%.
September 2026
The global automotive exhaust systems market size is valued at USD 91.67 billion in 2026 and is expected to hit around USD 139.77 billion by 2034, growing at a CAGR of 5.43% from 2026 to 2034.